|
000
| 01682cam 2200337zi 4500 |
|---|
| 001 | 9.928541 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20240129131053 |
|---|
| 006 | m o d f |
|---|
| 007 | cr ||||||||||| |
|---|
| 008 | 231011s2023 oncd ob f00| 0 eng d |
|---|
| 020 | |a9780660682532 |
|---|
| 040 | |aCaOODSP|beng|erda|cCaOODSP |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aH139-56/2023E-PDF |
|---|
| 100 | 1 |aGilbert, Marie-Line, |eauthor. |
|---|
| 245 | 10|aAt-a-glance : |bnew psychoactive substances in Canada - 2022 / |cMarie-Line Gilbert, Michèle Boileau-Falardeau, Caroline Maurice-Gelinas, Jean-François Chiasson, Janike Pitre, Benoit Archambault, Cindy Leung Soo. |
|---|
| 264 | 1|a[Ottawa] : |bHealth Canada = Santé Canada, |c2023. |
|---|
| 300 | |a1 online resource (15 pages) : |bcharts |
|---|
| 336 | |atext|btxt|2rdacontent |
|---|
| 337 | |acomputer|bc|2rdamedia |
|---|
| 338 | |aonline resource|bcr|2rdacarrier |
|---|
| 500 | |aIssued also in French under title: Survol : nouvelles substances psychoactives au Canada - 2022. |
|---|
| 504 | |aIncludes bibliographical references (page 15). |
|---|
| 520 | |a"The aim of this report is to describe NPS that emerged in Canada in 2022 based on samples submitted to the Drug Analysis Service (DAS) by law enforcement agencies and public health partners"--page 2. |
|---|
| 650 | 0|aPsychotropic drugs|zCanada. |
|---|
| 710 | 1 |aCanada. |bHealth Canada, |eissuing body. |
|---|
| 775 | 08|tSurvol : |w(CaOODSP)9.928542 |
|---|
| 856 | 40|qPDF|s2.17 MB|uhttps://publications.gc.ca/collections/collection_2024/sc-hc/H139-56-2023-eng.pdf |
|---|
| 856 | 4 |qHTML|sN/A|uhttps://www.canada.ca/en/health-canada/services/publications/healthy-living/new-psychoactive-substances-canada-2022.html |
|---|